Erythropoietin treatment in chronic phase chronic myeloid leukemia patients treated with frontline imatinib who developed late anemia.
Cesini, Laura
Erythropoietin treatment in chronic phase chronic myeloid leukemia patients treated with frontline imatinib who developed late anemia. [electronic resource] - European journal of haematology Sep 2020 - 286-291 p. digital
Publication Type: Journal Article; Multicenter Study
1600-0609
10.1111/ejh.13436 doi
Aged
Anemia--blood
Antineoplastic Agents--adverse effects
Biomarkers
Disease Management
Disease Susceptibility
Erythrocyte Indices
Erythropoietin--administration & dosage
Female
Humans
Imatinib Mesylate--adverse effects
Leukemia, Myeloid, Chronic-Phase--complications
Male
Middle Aged
Protein Kinase Inhibitors--adverse effects
Treatment Outcome
Erythropoietin treatment in chronic phase chronic myeloid leukemia patients treated with frontline imatinib who developed late anemia. [electronic resource] - European journal of haematology Sep 2020 - 286-291 p. digital
Publication Type: Journal Article; Multicenter Study
1600-0609
10.1111/ejh.13436 doi
Aged
Anemia--blood
Antineoplastic Agents--adverse effects
Biomarkers
Disease Management
Disease Susceptibility
Erythrocyte Indices
Erythropoietin--administration & dosage
Female
Humans
Imatinib Mesylate--adverse effects
Leukemia, Myeloid, Chronic-Phase--complications
Male
Middle Aged
Protein Kinase Inhibitors--adverse effects
Treatment Outcome